CCO Independent Conference Coverage

American Society of Hematology 2008 Annual Meeting*

December 6-9, 2008 | San Francisco, California

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Acute Leukemias/Myelodysplastic Syndromes

Track 1 of 4

Program Director: Roy A. Beveridge, MD

Faculty:
		Hagop M. Kantarjian, MD Alan F. List, MD Martin S. Tallman, MD
		Robert S. Mocharnuk, MD

Chronic Lymphocytic Leukemia/Chronic Myeloid Leukemia

Track 2 of 4

Capsule Summaries

Expert Analysis

Program Director: Roy A. Beveridge, MD

Faculty:
		Brian Druker, MD Kanti Rai, MD William G. Wierda, MD, PhD
		Allen S. Yang, MD, PhD

Lymphomas

Track 3 of 4

CME Program Director: Roy A. Beveridge, MD

Faculty:
		Steven H. Bernstein, MD Owen A. O'Connor, MD, PhD Julie M. Vose, MD
		Peter J. Rosen, MD

Multiple Myeloma/Plasma Cell Disorders

Track 4 of 4

Program Director: Roy A. Beveridge, MD

Faculty:
		William I. Bensinger, MD Sagar Lonial, MD Paul G. Richardson, MD
		Edward A. Stadtmauer, MD

Other Studies of Interest

Expert Viewpoint:

Howard Liebman, MD, reviews current thinking regarding idiopathic thrombocytopenic purpura, including studies presented at the 2008 hematology meeting.

Advances in the Treatment of Immune Thrombocytopenic Purpura

Capsule Summaries:

Erythropoiesis Stimulating Agents - ESAs

Increased Mortality and Decreased Survival Associated With Use of Erythropoiesis-Stimulating Agents in Cancer Patients

Idiopathic Thrombocytopenic Purpura - ITP

Expert Highlights

Choose a highlight from the list below:

Updates in CLL

Kanti Rai, MD, discusses updates in CLL therapies, including lenalidomide in the frontline setting, FCR data from the REACH trial, and the novel agent ofatumumab.

Audio File 5.87 MB

Windows Video 18.5 MB

Quicktime Video 28.0 MB

iPod Video 89.8 MB

Expert Highlight: ESAs in Cancer

Expert Highlight: Acute Leukemias and Myelodysplastic Syndromes

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.